Fernando Caravaggio
Fernando Caravaggio
University of Toronto. Centre for Addiction & Mental Health.
Verified email at camh.ca
Title
Cited by
Cited by
Year
The potential role of dopamine D3 receptor neurotransmission in cognition
S Nakajima, P Gerretsen, H Takeuchi, F Caravaggio, T Chow, B Le Foll, ...
European Neuropsychopharmacology 23 (8), 799-813, 2013
1172013
Glutamate-mediated excitotoxicity in schizophrenia: a review
E Plitman, S Nakajima, C de la Fuente-Sandoval, P Gerretsen, ...
European Neuropsychopharmacology 24 (10), 1591-1605, 2014
882014
Kynurenic acid in schizophrenia: a systematic review and meta-analysis
E Plitman, Y Iwata, F Caravaggio, S Nakajima, JK Chung, P Gerretsen, ...
Schizophrenia bulletin 43 (4), 764-777, 2017
642017
Effects of glutamate positive modulators on cognitive deficits in schizophrenia: a systematic review and meta-analysis of double-blind randomized controlled trials
Y Iwata, S Nakajima, T Suzuki, RSE Keefe, E Plitman, JK Chung, ...
Molecular psychiatry 20 (10), 1151-1160, 2015
622015
Neuroimaging findings in treatment-resistant schizophrenia: a systematic review: lack of neuroimaging correlates of treatment-resistant schizophrenia
S Nakajima, H Takeuchi, E Plitman, G Fervaha, P Gerretsen, ...
Schizophrenia research 164 (1-3), 164-175, 2015
602015
Evaluation of antipsychotic dose reduction in late-life schizophrenia: a prospective dopamine D2/3 receptor occupancy study
A Graff-Guerrero, TK Rajji, BH Mulsant, S Nakajima, F Caravaggio, ...
JAMA psychiatry 72 (9), 927-934, 2015
542015
Reduced insulin sensitivity is related to less endogenous dopamine at D2/3 receptors in the ventral striatum of healthy nonobese humans
F Caravaggio, C Borlido, M Hahn, Z Feng, G Fervaha, P Gerretsen, ...
International Journal of Neuropsychopharmacology 18 (7), 2015
472015
Ventral striatum binding of a dopamine D2/3 receptor agonist but not antagonist predicts normal body mass index
F Caravaggio, S Raitsin, P Gerretsen, S Nakajima, A Wilson, ...
Biological psychiatry 77 (2), 196-202, 2015
422015
Lifetime history of depression predicts increased amyloid-β accumulation in patients with mild cognitive impairment
JK Chung, E Plitman, S Nakajima, TW Chow, MM Chakravarty, ...
Journal of Alzheimer's Disease 45 (3), 907-919, 2015
402015
Antipsychotics, metabolic adverse effects, and cognitive function in schizophrenia
NE MacKenzie, C Kowalchuk, SM Agarwal, KA Costa-Dookhan, ...
Frontiers in psychiatry 9, 622, 2018
352018
Estimating endogenous dopamine levels at D 2 and D 3 receptors in humans using the agonist radiotracer [11 C]-(+)-PHNO
F Caravaggio, S Nakajima, C Borlido, G Remington, P Gerretsen, ...
Neuropsychopharmacology 39 (12), 2769-2776, 2014
302014
The VAGUS insight into psychosis scale–self-report and clinician-rated versions
P Gerretsen, G Remington, C Borlido, L Quilty, S Hassan, G Polsinelli, ...
Psychiatry research 220 (3), 1084-1089, 2014
292014
Comparative efficacy between clozapine and other atypical antipsychotics on depressive symptoms in patients with schizophrenia: analysis of the CATIE phase 2E data
S Nakajima, H Takeuchi, G Fervaha, E Plitman, JK Chung, F Caravaggio, ...
Schizophrenia research 161 (2-3), 429-433, 2015
282015
Cortical amyloid β deposition and current depressive symptoms in Alzheimer disease and mild cognitive impairment
JK Chung, E Plitman, S Nakajima, MM Chakravarty, F Caravaggio, ...
Journal of geriatric psychiatry and neurology 29 (3), 149-159, 2016
242016
Neurometabolite levels in antipsychotic-naïve/free patients with schizophrenia: A systematic review and meta-analysis of 1H-MRS studies
Y Iwata, S Nakajima, E Plitman, Y Mihashi, F Caravaggio, JK Chung, ...
Progress in Neuro-Psychopharmacology and Biological Psychiatry 86, 340-352, 2018
222018
Depressive symptoms and small hippocampal volume accelerate the progression to dementia from mild cognitive impairment
JK Chung, E Plitman, S Nakajima, MM Chakravarty, F Caravaggio, ...
Journal of Alzheimer's Disease 49 (3), 743-754, 2016
212016
Glutamatergic neurometabolite levels in patients with ultra-treatment-resistant schizophrenia: a cross-sectional 3T proton magnetic resonance spectroscopy study
Y Iwata, S Nakajima, E Plitman, F Caravaggio, J Kim, P Shah, W Mar, ...
Biological psychiatry 85 (7), 596-605, 2019
202019
Dopamine D 2/3 Receptor Occupancy Following Dose Reduction Is Predictable With Minimal Plasma Antipsychotic Concentrations: An Open-Label …
S Nakajima, H Uchida, RR Bies, F Caravaggio, T Suzuki, E Plitman, ...
Schizophrenia bulletin 42 (1), 212-219, 2016
202016
The effect of striatal dopamine depletion on striatal and cortical glutamate: A mini-review
F Caravaggio, S Nakajima, E Plitman, P Gerretsen, JK Chung, Y Iwata, ...
Progress in Neuro-Psychopharmacology and Biological Psychiatry 65, 49-53, 2016
182016
Examining endogenous dopamine in treated schizophrenia using [11C]-(+)-PHNO positron emission tomography: A pilot study
F Caravaggio, C Borlido, A Wilson, A Graff-Guerrero
Clinica Chimica Acta 449, 60-62, 2015
182015
The system can't perform the operation now. Try again later.
Articles 1–20